Literature DB >> 1699866

Megakaryocytes in myelodysplasia: an immunohistochemical study on bone marrow trephines.

S B Fox1, J Lorenzen, A Heryet, M Jones, K C Gatter, D Y Mason.   

Abstract

Megakaryocytes in 63 bone marrow trephine biopsies were examined for their staining characteristics, location and size distribution using the monoclonal antibody Y2/51 directed against platelet glycoprotein IIIa (CD61). Megakaryocytes in normal bone marrow were evenly distributed and demonstrated homogeneous staining with Y2/51. In addition, there was little variation in their size or shape. In contrast, myelodysplastic and myeloproliferative bone marrow trephines showed considerable dysmegakaryopoiesis demonstrated by heterogeneity of staining, an altered architectural distribution with a predominantly paratrabecular location and considerable variation in size and shape. Furthermore, in myelodysplasia 25% of the CD61 positive cells were micromegakaryocytes as opposed to less than 10% in normal or reactive marrows. Such dysmegakaryopoiesis is believed to be a clinically important feature of myelodysplasia, although until now it has only been possible to assess it subjectively. The availability of the monoclonal antibody Y2/51 provides a rapid and reproducible means of studying megakaryocyte size, shape and distribution in routine trephine specimens and may help to overcome some of the diagnostic problems currently associated with myelodysplasia and other intrinsic bone marrow neoplasias.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1699866     DOI: 10.1111/j.1365-2559.1990.tb00665.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  6 in total

1.  Dysmegakaryopoiesis in myelodysplastic syndromes (MDS): an immunomorphometric study of bone marrow trephine biopsy specimens.

Authors:  J Thiele; H Quitmann; S Wagner; R Fischer
Journal:  J Clin Pathol       Date:  1991-04       Impact factor: 3.411

Review 2.  Megakaryocytopoiesis in haematological disorders: diagnostic features of bone marrow biopsies. An overview.

Authors:  J Thiele; R Fischer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

3.  Physiological Srsf2 P95H expression causes impaired hematopoietic stem cell functions and aberrant RNA splicing in mice.

Authors:  Ayana Kon; Satoshi Yamazaki; Yasuhito Nannya; Keisuke Kataoka; Yasunori Ota; Masahiro Marshall Nakagawa; Kenichi Yoshida; Yusuke Shiozawa; Maiko Morita; Tetsuichi Yoshizato; Masashi Sanada; Manabu Nakayama; Haruhiko Koseki; Hiromitsu Nakauchi; Seishi Ogawa
Journal:  Blood       Date:  2017-11-16       Impact factor: 22.113

Review 4.  Myeloproliferative disorders and their effects on bone homeostasis: the role of megakaryocytes.

Authors:  Aikaterini Karagianni; Katya Ravid
Journal:  Blood       Date:  2022-05-26       Impact factor: 25.476

5.  QBEND10 for the diagnosis of myelodysplastic syndromes in routinely processed bone marrow biopsy specimens.

Authors:  H P Horny; M Wehrmann; H U Schlicker; A Eichstaedt; M R Clemens; E Kaiserling
Journal:  J Clin Pathol       Date:  1995-04       Impact factor: 3.411

6.  Inhibition of Osteoblast Differentiation by JAK2V617F Megakaryocytes Derived From Male Mice With Primary Myelofibrosis.

Authors:  Aikaterini Karagianni; Shinobu Matsuura; Louis C Gerstenfeld; Katya Ravid
Journal:  Front Oncol       Date:  2022-07-08       Impact factor: 5.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.